Cargando…

Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis

INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in patients with rheumatoid arthritis (RA). Some studies have reported a decrease in CVD in patients with RA using hydroxychloroquine (HCQ). Most of these have had fewer participants and have analyzed only composite outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cordova Sanchez, Andres, Khokhar, Farzam, Olonoff, Danielle A., Carhart, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532807/ https://www.ncbi.nlm.nih.gov/pubmed/36197529 http://dx.doi.org/10.1007/s10557-022-07387-z

Ejemplares similares

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients
por: Sharma, Tarun S., et al.
Publicado: (2016)

The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022)

The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients
por: Shapiro, Michael, et al.
Publicado: (2017)

Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
por: Nazir, Armaan M, et al.
Publicado: (2021)

Protective effect of hydroxychloroquine on rheumatoid arthritis‐associated atherosclerosis
por: Shi, Na, et al.
Publicado: (2019)

Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis
por: Zhang, Zhibo, et al.
Publicado: (2023)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine
por: Esser, Eliane Luisa, et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Diagnosing Spinal Gout: A Rare Case of Back Pain and Fever
por: Cordova Sanchez, Andres, et al.
Publicado: (2021)

Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
por: Gouze, Hélène, et al.
Publicado: (2022)

Endomyocardial biopsy-proven hydroxychloroquine-induced cardiomyopathy in a patient with rheumatoid arthritis
por: Malhotra, Anureet, et al.
Publicado: (2023)

Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: A Veterans Affair cohort
por: Guevara, Myriam, et al.
Publicado: (2021)

Double Jeopardy Cardiomyopathy Requiring Heart Transplant: Hydroxychloroquine and Rheumatoid Arthritis
por: Muthukumar, Lakshmi, et al.
Publicado: (2020)

The relationship between hydroxychloroquine plasma concentration and COVID-19 outcomes in rheumatoid arthritis patients in Saudi Arabia
por: Walbi, Ismail A., et al.
Publicado: (2022)

Hyperuricemia and Incident Cardiovascular Disease and Noncardiac Vascular Events in Patients with Rheumatoid Arthritis
por: Kuo, Daniel, et al.
Publicado: (2014)

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Hydroxychloroquine for treatment of rheumatoid arthritis: multifocal electroretinogram and laser flare-cell photometry study
por: Sebastiani, Stefano, et al.
Publicado: (2017)

A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis
por: Sotgia, Salvatore, et al.
Publicado: (2022)

The Importance of Early Pericardiectomy in Mulibrey Nanism Syndrome, a Case Report
por: Cordova Sanchez, Andres, et al.
Publicado: (2022)

15-Hydroxyprostaglandin dehydrogenase is upregulated by hydroxychloroquine in rheumatoid arthritis fibroblast-like synoviocytes
por: KIM, HAK-JAE, et al.
Publicado: (2015)

Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis
por: Lin, Ching-Tsai, et al.
Publicado: (2023)

Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
por: Baoqi, Yang, et al.
Publicado: (2022)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
por: da Silva, Juliana Cruz, et al.
Publicado: (2013)

Cardiovascular risk score in Rheumatoid Arthritis
por: Wagan, Abrar Ahmed, et al.
Publicado: (2016)

Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
por: Sun, Kai-jun, et al.
Publicado: (2021)

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients With Normal Fundoscopic Findings
por: Motarjemizadeh, Qader, et al.
Publicado: (2016)

Hormonal and Reproductive Factors in Relation to Cardiovascular Events in Women with Early Rheumatoid Arthritis
por: Boman, Antonia, et al.
Publicado: (2022)

Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Alonso-Molero, Jéssica, et al.
Publicado: (2020)

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
por: Dougados, Maxime, et al.
Publicado: (2023)

Modifiable cardiovascular risk factors in Rheumatoid Arthritis
por: Wagan, Abrar Ahmed, et al.
Publicado: (2017)

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

Patient Perception of Cardiovascular Risk in Rheumatoid Arthritis
por: Banerjee, Shubhasree, et al.
Publicado: (2020)

Frequency of Cardiovascular Manifestation in Patients With Rheumatoid Arthritis
por: Kumar, Pardeep, et al.
Publicado: (2021)

Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients
por: Teruel, María, et al.
Publicado: (2011)

Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
por: Fehlman, Jennifer Albus, et al.
Publicado: (2017)

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative
por: Carbone, Laura, et al.
Publicado: (2020)

The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
por: Han, Jiaochan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ou703nkq8vpujvgqci3u1l6ect